Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Agnantis

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
European Journal of Gynaecological Oncology|August 3, 2004
Aggressive angiomyxoma of the vagina: a case report and review of the literatureD J Papachristou, A Batistatou, E Paraskevaidis, et al.
In Vivo (Athens, Greece)|September 17, 2004
Tumor markers in cancer patients. an update of their prognostic significance. Part IIN J Agnantis, A C Goussia, A Batistatou, et al.
Anticancer Research|September 1, 1994
Comparative immunohistochemical study of ras-p21 oncoprotein in adenomatous hyperplasia and adenocarcinoma of the prostate glandN J Agnantis, A E Constantinidou, M Papaevagelou, et al.
Oncology|January 1, 1986
Comparative study of Harvey-ras oncogene expression with conventional clinicopathologic parameters of breast cancerN J Agnantis, P Parissi, D Anagnostakis, et al.
Anticancer Research|September 1, 1986
Immunohistochemical study of the ras oncogene expression in human breast lesionsN J Agnantis, C Petraki, P Markoulatos, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
The reliability of frozen-section diagnosis in various breast lesions: a study based on 3451 biopsiesN J Agnantis, N Apostolikas, I Christodoulou, et al.
Histology and Histopathology|March 17, 2004
p63 expression in benign and malignant breast lesionsD Stefanou, A Batistatou, A Nonni, et al.
European Journal of Gynaecological Oncology|August 3, 2004
Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experienceD Stefanou, A Batistatou, E Briasoulis, et al.
Pathology, Research and Practice|September 1, 1994
Histological findings in breast tissue specimens from reduction mammoplastiesV Karabela-Bouropoulou, G Liapi-Avgeri, E Iliopoulou, et al.
Anticancer Research|January 1, 1997
p53 DO-1 immunohistochemical overexpression in premalignant and malignant cervical lesionsA Skopelitou, S Kamina, O Krikoni, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
European Journal of Gynaecological Oncology|August 3, 2004
Aggressive angiomyxoma of the vagina: a case report and review of the literatureD J Papachristou, A Batistatou, E Paraskevaidis, et al.
In Vivo (Athens, Greece)|September 17, 2004
Tumor markers in cancer patients. an update of their prognostic significance. Part IIN J Agnantis, A C Goussia, A Batistatou, et al.
Anticancer Research|September 1, 1994
Comparative immunohistochemical study of ras-p21 oncoprotein in adenomatous hyperplasia and adenocarcinoma of the prostate glandN J Agnantis, A E Constantinidou, M Papaevagelou, et al.
Oncology|January 1, 1986
Comparative study of Harvey-ras oncogene expression with conventional clinicopathologic parameters of breast cancerN J Agnantis, P Parissi, D Anagnostakis, et al.
Anticancer Research|September 1, 1986
Immunohistochemical study of the ras oncogene expression in human breast lesionsN J Agnantis, C Petraki, P Markoulatos, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
The reliability of frozen-section diagnosis in various breast lesions: a study based on 3451 biopsiesN J Agnantis, N Apostolikas, I Christodoulou, et al.
Histology and Histopathology|March 17, 2004
p63 expression in benign and malignant breast lesionsD Stefanou, A Batistatou, A Nonni, et al.
European Journal of Gynaecological Oncology|August 3, 2004
Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experienceD Stefanou, A Batistatou, E Briasoulis, et al.
Pathology, Research and Practice|September 1, 1994
Histological findings in breast tissue specimens from reduction mammoplastiesV Karabela-Bouropoulou, G Liapi-Avgeri, E Iliopoulou, et al.
Anticancer Research|January 1, 1997
p53 DO-1 immunohistochemical overexpression in premalignant and malignant cervical lesionsA Skopelitou, S Kamina, O Krikoni, et al.
Pageof 13